标题
Engineering an anti-HER2 biparatopic antibody with a multimodal mechanism of action
作者
关键词
-
出版物
Nature Communications
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-06-18
DOI
10.1038/s41467-021-23948-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Apoptosis-inducing anti-HER2 agents operate through oligomerization-induced receptor immobilization
- (2021) Jakob C. Stüber et al. Communications Biology
- Systemic analysis of tyrosine kinase signaling reveals a common adaptive response program in a HER2-positive breast cancer
- (2019) Martin Schwill et al. Science Signaling
- High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features
- (2019) Juan Rosa-Rosa et al. Cancers
- Inhibition of the MET Kinase Activity and Cell Growth in MET-Addicted Cancer Cells by Bi-Paratopic Linking
- (2019) Fabio Andres et al. JOURNAL OF MOLECULAR BIOLOGY
- High-Throughput Quantification of Surface Protein Internalization and Degradation
- (2019) Jakob C. Stüber et al. ACS Chemical Biology
- EGR1 interacts with DNMT3L to inhibit the transcription of miR‐195 and plays an anti‐apoptotic role in the development of gastric cancer
- (2019) Yang Yang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Influence of size and charge of unstructured polypeptides on pharmacokinetics and biodistribution of targeted fusion proteins
- (2019) Fabian Brandl et al. JOURNAL OF CONTROLLED RELEASE
- Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade
- (2018) Cecile A.W. Geuijen et al. CANCER CELL
- Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody
- (2018) Vaheh Oganesyan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Single-molecule imaging reveals dynamic biphasic partition of RNA-binding proteins in stress granules
- (2018) Benedikt Niewidok et al. JOURNAL OF CELL BIOLOGY
- A human endothelial cell-based recycling assay for screening of FcRn targeted molecules
- (2018) Algirdas Grevys et al. Nature Communications
- Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer
- (2018) Chaoran Yu et al. World Journal of Surgical Oncology
- Antibodies to watch in 2019
- (2018) Hélène Kaplon et al. mAbs
- The making of bispecific antibodies
- (2017) Ulrich Brinkmann et al. mAbs
- Next generation antibody drugs: pursuit of the 'high-hanging fruit'
- (2017) Paul J. Carter et al. NATURE REVIEWS DRUG DISCOVERY
- Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
- (2017) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rigidity of the extracellular part of HER2: Evidence from engineering subdomain interfaces and shared-helix DARPin-DARPin fusions
- (2017) Christian Jost et al. PROTEIN SCIENCE
- A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
- (2016) John Y. Li et al. CANCER CELL
- Generation and characterization of ABBV642, a dual variable domain immunoglobulin molecule (DVD-Ig) that potently neutralizes VEGF and PDGF-BB and is designed for the treatment of exudative age-related macular degeneration
- (2016) Kun Ding et al. mAbs
- Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cells
- (2016) Michael Dillon et al. mAbs
- A Potent HER3 Monoclonal Antibody That Blocks Both Ligand-Dependent and -Independent Activities: Differential Impacts of PTEN Status on Tumor Response
- (2016) Z. Xiao et al. MOLECULAR CANCER THERAPEUTICS
- The Perseus computational platform for comprehensive analysis of (prote)omics data
- (2016) Stefka Tyanova et al. NATURE METHODS
- COSMIC: somatic cancer genetics at high-resolution
- (2016) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Intermolecular biparatopic trapping of ErbB2 prevents compensatory activation of PI3K/AKT via RAS–p110 crosstalk
- (2016) Rastislav Tamaskovic et al. Nature Communications
- An anti-ErbB2 fully human antibody circumvents trastuzumab resistance
- (2016) Qiong Lu et al. Oncotarget
- Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy
- (2015) Andreas Plückthun Annual Review of Pharmacology and Toxicology
- Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity
- (2015) H. J. Jacobsen et al. CLINICAL CANCER RESEARCH
- Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer
- (2015) Michael Kloth et al. GUT
- Targeting Three Distinct HER2 Domains with a Recombinant Antibody Mixture Overcomes Trastuzumab Resistance
- (2015) M. W. Pedersen et al. MOLECULAR CANCER THERAPEUTICS
- Expression Atlas update—an integrated database of gene and protein expression in humans, animals and plants
- (2015) Robert Petryszak et al. NUCLEIC ACIDS RESEARCH
- Effective Optimization of Antibody Affinity by Phage Display Integrated with High-Throughput DNA Synthesis and Sequencing Technologies
- (2015) Dongmei Hu et al. PLoS One
- Molecular architecture of the ErbB2 extracellular domain homodimer
- (2015) Shi Hu et al. Oncotarget
- Identification of Anti-ErbB2 Dual Variable Domain Immunoglobulin (DVD-Ig™) Proteins with Unique Activities
- (2014) Jinming Gu et al. PLoS One
- voom: precision weights unlock linear model analysis tools for RNA-seq read counts
- (2014) Charity W Law et al. GENOME BIOLOGY
- An Antibody That Locks HER3 in the Inactive Conformation Inhibits Tumor Growth Driven by HER2 or Neuregulin
- (2013) A. P. Garner et al. CANCER RESEARCH
- Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding to the Extracellular Domain of HER2
- (2013) Christian Jost et al. STRUCTURE
- Protein analysis by time-resolved measurements with an electro-switchable DNA chip
- (2013) Andreas Langer et al. Nature Communications
- Three-dimensional cell culture: the missing link in drug discovery
- (2012) Susan Breslin et al. DRUG DISCOVERY TODAY
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Camera: a competitive gene set test accounting for inter-gene correlation
- (2012) Di Wu et al. NUCLEIC ACIDS RESEARCH
- Resistance to HER2-directed antibodies and tyrosine kinase inhibitors
- (2011) Joan T. Garrett et al. CANCER BIOLOGY & THERAPY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
- (2011) J. T. Garrett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recycling
- (2010) J. B. Spangler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Augmented inhibition of angiogenesis by combination of HER2 antibody chA21 and trastuzumab in human ovarian carcinoma xenograft
- (2010) Anli Zhang et al. Journal of Ovarian Research
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes
- (2009) E. A. Mittendorf et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started